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SuperoxideAortic abdominal aneurysms (AAA) are important causes of cardiovascular morbidity and mortality. Oxidative
stress may link multiple mechanisms of AAA including vascular inflammation and increased metalloproteinase
activity. However, the mechanisms of vascular free radical production remain unknown. Accordingly, we aimed
to determine sources and molecular regulation of vascular superoxide (O2•−) production in human AAA.
Methods and results: AAA segments and matched non-dilated aortic samples were obtained from 40 subjects
undergoing AAA repair. MDA levels (determined by HPLC/MS) were greater in plasma of AAA subjects (n=16)
than in risk factor matched controls (n=16). Similarly, superoxide production, measured by lucigenin chemi-
luminescence and dihydroethidium fluorescence, was increased in aneurysmatic segments compared to
non-dilated aortic specimens. NADPH oxidases and iNOS are the primary sources of O2•− in AAA. Xanthine
oxidase, mitochondrial oxidases and cyclooxygenase inhibition had minor or no effect. Protein kinase C inhi-
bition had no effect on superoxide production in AAA. NADPH oxidase subunit mRNA levels for p22phox, nox2
and nox5 were significantly increased in AAAs while nox4 mRNA expression was lower. Superoxide produc-
tion was higher in subjects with increased AAA repair risk Vanzetto score and was significantly associated
with smoking, hypercholesterolemia and presence of CAD in AAA cohort. Basal superoxide production and
NADPH oxidase activity were correlated to aneurysm size.
Conclusions: Increased expression and activity of NADPH oxidases are important mechanisms underlying
oxidative stress in human aortic abdominal aneurysm. Uncoupled iNOS may link oxidative stress to inflam-
mation in AAA. Oxidative stress is related to aneurysm size and major clinical risk factors in AAA patients.
Crown Copyright © 2013 Published by Elsevier Ireland Ltd. Open access under CC BY license.1. Introduction
Aortic abdominal aneurysms (AAA) are important causes of car-
diovascular morbidity and mortality [1]. They occur in 8% of men
after 60 years of age, and are associated with unfavorable prognosis
[1]. The mechanisms of AAA are complex and include increased
metalloproteinase activity, vascular inflammation, mechanical stress
and increased reactive oxygen species (ROS) production in the vesseloratory, Department of Internal
of Medicine, J Dietl Hospital, Ul.
3.
e reliability and freedom from
tion. No conflicts of interests to
ier Ireland Ltd. Open access under CC wall [1]. In spite of many years of research, we are still lacking effec-
tive medial therapy for AAA [2]. Therefore, it is imperative to better
understand the mechanisms of this important disease and to provide
new, specific drug targets for the treatment of AAA.
Recent studies have pointed out, that oxidative stress can provide
a link between most known mechanisms of AAA. Reactive oxygen
species production is induced by mechanical stress to the vascular
wall or by cytokines. Overproduction of ROS may subsequently in-
duce inflammation, matrix metalloproteinase (MMP) activity, smooth
muscle cell apoptosis or changes in collagen properties [3]. NADPH
oxidases are the major sources of superoxide anion in human and an-
imal vasculature [3,4]. Studies in murine models of AAA demonstrate
that NADPH oxidases and the iNOS are also critical for free radical
production in aneurysms [5]. Loss of these enzymes prevents the devel-
opment of AAA, through reduced expression of MMP-2 and MMP-9
in the aortic tissues [5]. For example, p47phox−/− mice, which lackBY license.
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apocynin are protected from AAA formation [5,6].
Role of local oxidative stress in the pathogenesis of AAA has been
much investigated in humans. Some studies have shown that markers
of systemic oxidative stress such as malondialdehyde (MDA) are in-
creased in AAApatients [7,8]. Moreover, Miller et al. have demonstrated
increased local production of superoxide anion in human aneurysms
and suggested that these radicals may come from NADPH oxidases
[9,10]. However, the enzymatic and molecular mechanisms of ROS
overproduction in human AAA have not been systematically analyzed
so far. It is not clear, if the sources are similar to the ones described
in animal models. Given vital structural and functional differences be-
tween human and mouse aorta, it is an important issue. Moreover, the
relationship between clinical risk profile/parameters of the AAA and
local vascular oxidative stress remains unclear. Identification of these
mechanisms and relationships is critical for the possibility of designing
future AAA prevention strategies.
In the present study, using oxidase inhibitors, we identified that
NADPH oxidases and iNOS are the primary sources of superoxide
anion overproduction in human AAA.
We find, that the expression of NADPH oxidase homologs Nox2
and Nox5 is increased, while Nox4mRNA is decreasedwhen compared
to aorta from non-AAA patients. More importantly, we show for the
first time, that superoxide production in aneurysmatic aortic wall is re-
lated to overall mortality risk and to aneurysm size, as well as smoking,
hypercholesterolemia and the presence of coronary artery disease.
Our study identifies NADPH oxidases and uncoupled iNOS as impor-
tant drug targets for anti-oxidative strategies in human AAA treatment.
Some therapies, already available, can have significant effects on oxida-
tive stress and inflammation in human aneurysms. For example, simva-
statin may reduce both ROS production and vascular inflammation in
AAA [11]. Inhibition of NADPH oxidases is one of the important pleio-
tropic effects of statins, however future treatments could be directed
more specifically on inhibiting NADPH oxidases or iNOS in AAA [12].
2. Materials and methods
2.1. Patients and blood vessels
Segments of abdominal aortic aneurysms were obtained during AAA repair surgery
at the site of maximal dilatation from 40 patients. In some patients, matching small
fragments from non-aneurysmatic wall of the vessel were obtained. Detailed clinical data
includingmajor risk factors for atherosclerosis and AAA, aswell as intra-operatively deter-
mined size of the AAA were recorded at the time of surgery.
Immediately after harvesting, vascular segmentswere placed in ice-coldKrebs-HEPES
buffer and transported to the laboratory for determinations of vascular superoxide
production.
In a subgroup of patients, fragments of aortic tissues were saved for cryosections
or saved in RNA later solution for subsequent RNA extraction. In a separate group of
5 patients, small segments of aorta were obtained from control subjects undergoing
coronary artery bypass graft (CABG) surgery from sites of bypass graft implantation
into the aorta and were used for determination or Nox mRNA expression. CABG patients
studied were exactly matched for major risk factors to AAA patients fromwhom samples
were obtained for RNA determination. Coronary artery disease (CAD) was defined by
clinical history of acute coronary events or positive coronary angiography. Clinical risk
factors were categorized as follows: hypercholesterolemia (total plasma cholesterol
level >5 mmol/L); smoking (current or within last 6 months); diabetes (fasting glucose
level >7 mmol/L or HbA1c>6.5% or current treatment with insulin or oral hypoglycemic
agents); and hypertension (blood pressure>140/90 or current treatment with antihy-
pertensive agents), based on [13]. Mortality risk was assessed in AAA patients using
Vanzetto score [14].
Additionally, blood was obtained from matched: 16 AAA and 16 control CAD sub-
jects and was stored for measurements of malondialdehyde (MDA). Ultrasound was
used to exclude the presence of AAA in subjects in control group.
Collection of tissues has been approved by the Local Research Ethics Committee and
informed consent was obtained. The authors of this manuscript have certified that they
comply with the Principles of Ethical Publishing in the International Journal of Cardiology.
2.2. Malondialdehyde (MDA) determination
Blood for determination of malondialdehyde (MDA) was collected into sodium
citrate and was centrifuged at 1300 RCF (g) at 4 °C and plasma was stored at −80 °C
until measurements were performed.MDA was determined using liquid chromatography with mass spec detection
(HPLC/MS; LCQ Finnigan Matt). A modified technique described in detail by Sim et al.
[15] was used. Briefly diluted (10%) samples were incubated with NaOH for 60 min
in order to release MDA bound in tissues. The hydrolyzed sample was acidified using
35% (v/v) perchloric acid. Supernatant was then subjected to double extraction using
n-hexane. Organic phase was then analyzed using HPLC/MS.
2.3. Vascular superoxide production
Superoxide production was measured from intact vessel segments using lucigenin-
enhanced chemiluminescence (LGCL; 5 μmol/L), utilizing previously described and val-
idatedmethods [4,16]. Specificity for superoxidewas confirmedbypre-incubation of vascu-
lar segments with PEG-SOD (500 IU/mL) or Mn(III)tetrakis(4-benzoic acid)porphyrin
chloride (MnTBAP; 25 μmol/L). The maximal activity of NAD(P)H oxidase was measured
by adding NADPH (100 μM/L), and O2•− was detected using 5 μmol/L lucigenin as pub-
lished before [16,17]. In separate experiments segments of AAA were pre-incubated with
various oxidase inhibitors such as apocynin (300 μmol/L), diphenyleneiodonium (DPI;
10 μmol/L); allopurinol (100 μmol/L), rotenone (100 μmol/L), indomethacin (10 μmol/L),
nitric oxide synthase (L-NAME, 100 μmol/L), N-(3-aminomethyl) benzylacetamidine
(1400W; 2 μmol/L) or chelerythrine (3 μmol/L) [16]. It has to be noted that not all inhib-
itors used in this study are entirely specific. For example, apocynin — initially thought
to be a specific inhibitor of NADPH oxidases possesses also non-specific anti-oxidant
properties [18].
2.4. Oxidative fluorescent microtopography
In situ superoxide generation was visualized in vascular cryosections (30 μm) with
the SOD-inhibitable dihydroethidium (DHE; 2 μmol/L) fluorescence, as described pre-
viously [16]. Images were obtained with a BioRad MRC 1024 scanning confocal micro-
scope using the excitation/emission wavelengths 488 nm/610 nm. In each case, paired
segments of AAA and AAA pre-incubated with PEG-SOD (500 U/mL) were analyzed in
parallel with identical imaging parameters.
2.5. Quantitative real-time RT-PCR
RNA was isolated from aortic segments, previously protected with RNAlater RNA
Stabilization Reagent (QIAGEN), using Qiazol Lysis Reagent (QIAGEN) and purified
using RNeasy Lipid Tissue Mini Kit with DNAse digestion. The cDNA synthesized using
High-Capacity cDNA Reverse Transcription Kits from 20 ng total RNA was subjected to
quantitative PCR using TaqMan Gene Expression Assays (Applied Biosystem) and
7900HT Fast Real-Time PCR System (Applied Biosystem). GAPDH was used as a house-
keeping gene for aortic segments using TaqMan Gene Expression Assay. Delta–delta CT
was used to calculate mRNA expression for studied Nox homolog subunits. Data are
expressed as relative expression (RQ).
2.6. Statistical analysis
All data are expressed as mean±SD with n equal to the number of patients. To test
normality of distribution, D'Agostino & Pearson omnibus normality test was employed.
Comparisons between groups of patients or treatments were made using Student
t-test or one-way ANOVA, followed by the Student–Newman–Keuls post-hoc test.
When indicated, two way ANOVA was implemented. Non-normally distributed vari-
ables were analyzed using non-parametric tests such as Mann–Whitney U test or
Kruskal–Wallis ANOVA and are presented as median [10th–90th percentile]. Categorical
variables were compared by using chi-square test, as appropriate. Power calculations
based on our previous studies of MDA levels suggested that 16 subjects per group
would be able to detect a 30% difference in plasma MDA generation with α=0.05
and power 90%. Similar power calculations of vascular superoxide production showed
that 25 subjects per group would be able to detect a 30% difference in vascular super-
oxide generation with α=0.05 and power 90%.
Correlation between oxidase activity and aneurysm size was assessed by simple
linear regression. Moreover comparison of the relationship between AAA size and
NADPH-stimulated superoxide production was performed by comparison of vascular
O2 generation in groups divided by tertiles of AAA size using a non-parametric
Kruskal–Wallis ANOVA values of pb0.05 were considered statistically significant.
Prism 6.0 for Mac or PASW statistics 18.0 was used for analysis.
3. Results
3.1. Patient characteristics
Fresh abdominal aortic specimens were obtained from 40 patients
undergoing surgical AAA repair. The demographic and clinical charac-
teristics were typical for patients undergoing such surgery, with most
prevalent risk factors being male sex, smoking and hypertension
(Table 1). AAA patients presented with moderate to large diameters
of AAA as determined by pre-operative ultrasound determination
Table 1
Clinical characteristics of patients from whom aortic specimens and/or plasma were
obtained. CAD — coronary artery disease; BMI — body mass index; PAD — peripheral
arterial disease; TIA — transient ischemic attacks; ACE-I — Angiotensin Converting
Enzyme Inhibitor.
Control group AAA p value
N 16 40
Age (mean±SD)a 64.6±6.9 65.7±6.7 0.70
Sex (M:F)a 12:4 36:4 0.14
Risk factors
Smoking (n; %)a 12 (75%) 28 (70%) 0.70
Hypertension (n; %)a 12 (75%) 31 (77.5%) 0.84
Diabetes (n; %)a 1 (6.2%) 3 (7.5%) 0.87
Hypercholesterolemia (n; %)a 10 (62.5%) 26 (65%) 0.86
BMI 29.7±5.2 26.9±3.3 0.60
Cholesterol (mmol/L; mean±SD) 6.1±1.5 6.3±1.8 0.50
CAD (n; %)a 16 (100%) 36 (90%) 0.18
PAD, TIA (n; %) 5 (31%) 14 (35%) 0.78
Main medications
Aspirin 12 (75%) 27 (68%) 0.58
ACE-I 6 (37%) 25 (62.5%) 0.07
β-Blocker 9 (56%) 14 (35%) 0.14
Statin 10 (62.5%) 24 (60%) 0.86
a Indicates factors which were exactly matched for the comparison of MDA between
patients (data shown in Fig. 1).
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imal AAA sizes were greater than ones determined by USG although
no significant differences were found. Moreover in 31 subjects
(77.5%), a thrombus was observed in the lumen of the aneurysm.
Blood samples for MDA determination were obtained from 16 sub-
jects undergoing CABG surgery who matched clinical risk factor profile
(age, sex, hypertension, smoking, hypercholesterolemia and diabetes)
of 16 AAA patients in whom blood was also drawn (Table 1).
3.2. Systemic oxidative stress in AAA
Wemeasured malondialdehyde (MDA) levels in plasma of 16 AAA
and 16 control patients, exactly matched for major clinical risk factors,
which have been previously shown to potentially confound oxidative
stress measures. Plasma MDA levels were almost two-fold higher in
patients with abdominal aortic aneurysms, than in non-AAA CAD
group (Fig. 1A). Moreover, detailed analysis of individual patient pairs
exactly matched for factors described above, indicated that MDA levels
were consistently higher in AAA in all apart from 2 matched pairs
(Fig. 1B).
3.3. Vascular superoxide production in aortic abdominal aneurysms
Basal O2•− production, determined from freshly-isolated aortic ab-
dominal aneurysms, by LGCL (5 μmol/L), was greater in aneurysmatic
segment (isolated from the site maximal dilatation) than in non-
aneurysmatic segments of the aorta obtained from the same patient
(Fig. 2A). For reference, we have also measured O2•− production
from segments of aorta isolated from non AAA patients, obtained
during CABG at the sites of implantation of venous bypass grafts,
and found it to be comparable to the level of superoxide producedTable 2
Morphologic characteristics of studied aneurysms.
Parameter Average±SD
Ultrasound assessment Maximal AAA aortic size (L3) mm 64.5±17.8
Sub-diaphragmatic aortic size (L1) mm 26.0±4.1
Enlargement ratio (L3/L1) 2.4±0.6
Intraoperative
assessment
Maximal size mm 69.2±21.9
AAA with thrombus 77.5%by non-aneurysmatic areas of aorta in AAA subjects (11.5; SD
3.1 RLU/s/mg dw; n=5).
Moreover, in situ dihydroethidium staining showed that O2•− pro-
duction was observed in all vascular layers of aortic wall from AAA
patients, and that it appeared to be the highest at the adventitial
side of aneurysmatic aortic wall (Fig. 2B).
3.4. Sources of superoxide production in human abdominal aneurysms
We next investigated the enzymatic sources of O2•− production in
intact segments of human AAA aorta using a range of oxidase inhibitors
(Fig. 3A). The greatest inhibition of O2•− production in aortic segments
was caused by NADPH oxidase inhibitors (diphenyliodonium and
apocynin). Allopurinol, a xanthine oxidase inhibitor, did not decrease
vascular O2•− production. Similarly, oxypurinol, which was used in a
subset of experiments as an active metabolite of allopurinol, did not
have any significant effect (data not shown). Interestingly, an addi-
tional 20% inhibition of O2•− production in AAA aortas was observed
in response to indomethacin, the cyclooxygenase inhibitor.
Notably, significant effects were observed upon pre-incubation of
vascular segments with nitric oxide synthase inhibitors. Both L-NAME
(ca. 30% reduction) and 1400W (iNOS specific inhibitor; ca. 40%
reduction) resulted in a very significant reduction of basal O2•− pro-
duction in aortic abdominal aneurysms, indicating an involvement
of iNOS in superoxide generation in AAA.
These studies have identified NADPH oxidases as principal sources
of O2•− production in AAA. As vascular NADPH oxidases are commonly
regulated by protein kinase C, we next studied the role of protein
kinase C (PKC) in modulating vascular O2•− production. Inhibition of
PKC by chelerythrine did not affect basal vascular O2•− production in
AAA (Fig. 3B). We next studied effects of chelerythrine on NADPH-
stimulated oxidase activity in AAA aortas, but similarly to basal O2•−
production we found no effect of PKC inhibition on NADPH oxidase
activity in AAA (Fig. 3C).
Taken together, these findings suggest that NAD(P)H oxidases are
the major sources of superoxide in human AAA, with an additional
contribution of cyclooxygenases and iNOS. Surprisingly, increased
NAD(P)H oxidase activity in AAA is not regulated by PKC.
3.5. NAD(P)H oxidase subunits in human abdominal aneurysms
Since NAD(P)H oxidases appear to play the principal role in super-
oxide production by human abdominal aortic aneurysms, we next
sought to evaluate the NAD(P)H oxidase membrane subunit mRNA
expression in aortic AAA extracts. NAD(P)H oxidase subunit expres-
sion (nox1, nox2, nox3, nox4, nox5 and p22phox) was measured
using TaqMan quantitative real-time fluorescent RT-PCR. We found
that p22phox and nox2 mRNA levels were dramatically increased in
AAA segments when compared to control aortas (Fig. 4). Interestingly
a significantly higher expression of Nox5 was also observed. Very low
expression of Nox1 was found in only 2 out of 5 studied aortic ex-
tracts, while it was not observed in control vessels at all. However
due to very low level of expression this difference did not reach statis-
tical significance. Nox3 mRNA was not detectable in any of the studied
samples.
Interestingly we observed that Nox4 expression was lower in AAA
aortic extracts than in control samples (Fig. 4).
3.6. Superoxide production in AAA and risk profile
We next sought to determine the relationships between risk factors
for abdominal aneurysms and atherosclerosis with vascular superoxide
production in AAA. We therefore analyzed the difference in superoxide
production from AAA aortic segments between patients with low and
high risk profiles. Risk profile was determined using Vanzetto scale,
which is commonly used in the clinical practice to assess surgical
A B
Fig. 1. Abdominal aortic aneurysm is associated with systemic oxidative stress. Panel A. Malondialdehyde (MDA) levels in plasma of subjects with AAA and patients without AAA
(control group) with similar risk factor profile. Data are presented as median [10th–90th percentile]; (n=16 in each group) Panel B. Plasma MDA levels in 16 patient pairs, matched
exactly for age, sex, and major risk factors for atherosclerosis such as hypertension, hypercholesterolemia, smoking and diabetes.
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following clinical parameters to assess risk: age >70 years; coronary
artery disease, Q or ST changes in the ECG, co-existence of congestive
heart failure, hypertension or diabeteswith left ventricular hypertrophy.
We observed that subjects who presented with Vanzetto score >3
showed more than tripled superoxide production in their aortic seg-
ments (Fig. 5A), indicating a clear relationship between vascular super-
oxide production and risk in AAA patients undergoing AAA repair
surgery.
We next analyzed the effects of individual risk factors on O2•− pro-
duction in segments of AAA. Smoking, hypercholesterolemia andB
A
Fig. 2. Vascular superoxide production aortic segments from patients with AAA and
without AAA. Panel A. Basal superoxide production was measured by LGCL (5 μmol/L)
in intact segments of aorta obtained from aortic aneurysm at largest diameter point
(n=38) and from non-aneurysmatic segment (non AAA). Superoxide production was
expressed in RLU/s/mg dw. Specificity for superoxide was investigated by pre-incubation
with PEG-SOD (500 U/mL) or MnTBAP (25 μmol/L) *-pb0.01 vs. nonAAA; **-pb0.01 vs no
inhibitor. Panel B.Histochemical in situ detection of superoxide byDHE staining of abdominal
aorta sections obtained from AAA patient. Control sections were incubated with PEG-SOD
(500 U/mL). Photograph is representative of n=5 independent comparisons. A — indicates
adventitial side of aortic section.presence of coronary artery disease were most strongly associated
with vascular superoxide production (Table 3). It was surprising
that male sex, which is a very strong risk factor for AAA was not sig-
nificantly associated with O2•− production in AAA. On the contrary, it
appeared that women showed greater tendency towards increased
superoxide production than men. It should be however remembered
that majority of subjects in AAA group were male and hypertensive
(Table 1), thus the analysis of the effects of sex on superoxide produc-
tion in AAA may not have enough statistical power to draw meaning-
ful conclusions regarding effects of male sex or hypertension.
3.7. Aneurysm size and NADPH oxidase activity
We next studied the relationship between vascular basal and
NADPH-stimulated O2•− production from AAA and aneurysm size
determined intra-operatively. We observed statistically significant
positive correlations between these parameters, although correlation
between aneurysm size and NADPH-stimulated O2•− production (as a
measure of NADPH oxidase activity) was stronger than with basal
superoxide production (R=0.5; pb0.01 vs. R=0.3; pb0.05 using
the Spearman correlation test). As aneurysm size was not entirely
continuous variable, we grouped the patients in this figure according
to tertiles of AAA size and compared NADPH-stimulated superoxide
values across the tertiles by using a multiple comparisons Kruskal–
Wallis ANOVA test (p=0.0018) (Fig. 5B).
4. Discussion
Increased vascular oxidative stress is a feature of several vascular
diseases. In the present study we show that human abdominal aortic
aneurysms are associated with systemic oxidative stress and increased
local O2•− production within the aneurysm. Using pharmacological in-
hibitors we demonstrate, that the NADPH oxidases and iNOS are the
major sources of superoxide, and that cyclooxygenases may also mod-
estly contribute to O2•− production in AAA. NADPH oxidase activity
measured as NADPH-stimulated superoxide anion production is corre-
lated to the size of aneurysm. We also found that the NADPH oxidase
subunits p22phox, nox2 and nox5 are increased in AAA, while nox4
is reduced. Interestingly, we did not find the role for protein kinase C
in the regulation of vascular oxidases in AAA, in contrast to coronary
artery disease or diabetes [19]. Moreover, we describe that superoxide
production in AAA is significantly associated with several clinical risk
factors for atherosclerosis and that it is significantly higher in AAA seg-
ments obtained from patients with higher peri-operative risk score.
Previous studies have suggested that reactive oxygen species pro-
duction is increased in human AAA [9,10]. Here, we confirm, that O2•−
production is increased in AAA, when compared to non-aneurysmatic
regions of the aorta [10]. However, the difference between the two,
observed in the present study is smaller than previously reported by
Miller et al. [10]. We studied much larger patient population, but
A
B C
Fig. 3. Sources of vascular superoxide anion in human abdominal aortic aneurysms. Panel A. Superoxide production was determined by LGCL (5 μmol/L) in intact aortic segments
(n=6), following a 30 minute incubation with various oxidase inhibitors: NADPH oxidase (apocynin, 300 μmol/L, not entirely specific), diphenyleneiodonium (DPI; 10 μmol/L);
xanthine oxidase (allopurinol, 100 μmol/L), mitochondrial oxidases (rotenone, 100 μmol/L), cyclooxygenase (indomethacin, 10 μmol/L), nitric oxide synthase (L-NAME, 100 μmol/L)
or iNOS (1400W, 2 μmol/L). Panel B. Effects of protein kinase C inhibition on superoxide production in AAA. Basal (left graph) and NADPH (100 μmol/L) stimulated (right graph) super-
oxide productionwasmeasured in intact segments of AAA using LGCL (5 μmol/L). Adjacent segments were pre-incubated for 30 minwith or without an inhibitor and luminescence was
measured in the absence/presence of protein kinase C inhibitor chelerythrine (Chel) at 3 μmol/L.
A B C
D E F
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Fig. 4. Molecular composition of NAD(P)H oxidases in human abdominal aortic aneurysms (n=5) and aortic segments from risk-factor matched CABG patients (n=5). Quantitative
RT-PCR (TaqMan) of NADPH oxidase subunits p22phox (panel A), nox1 (panel B), nox2 (panel C), nox3 (panel D), nox4 (panel E) and nox5 (panel F) was determined using 20 ng
of total RNA. ddCT was used for calculation with GAPDH as a reference gene. Data are expressed as mean relative expression (RQ) ±SD; *-pb0.05 vs. non AAA; **-p=0.05; NS — non
significant; NE — not expressed.
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A B
Fig. 5. Relationship of clinical characteristics to vascular superoxide generation from AAA. Panel A. Superoxide production was determined by LGCL (5 μmol/L) in patients with
Vanzetto score≤3 and >3. Data are expressed as mean±SD. Panel B. Relationships between intra-operatively determined AAA size and NADPH-stimulated superoxide production
was (n=30) determined in AAA segments using LGCL (5 μmol/L) at the site of largest dilatation. Data is analyzed for tertiles of AAA size and non-parametric Kruskal–Wallis ANOVA
(p=0.0018) with post-hoc multiple comparisons was performed.
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other medications known to reduce reactive oxygen species produc-
tion in patients at high cardiovascular risk. Indeed, 60% of our subjects
used statins, while the statin use was not reported in the initial paper
[10].
Our study further extends these initial observations, by relating
vascular AAA superoxide production to clinical characteristics of the
patients. We have observed that AAA vascular superoxide production
is much higher in patients with high overall mortality risk assessed by
Vanzetto score [14]. This finding is important as it shows potential
clinical importance of increased oxidative stress in AAA, although it
needs to be further prospectively evaluated in a larger cohort of patients.
We used Vanzetto score as one of the comprehensive risk assessment
scores utilized in AAA patients. Recent studies clearly show that results
obtained with Vanzetto score are strongly correlated with risk stratifi-
cation using other clinical risk stratification scales such as Eagle score,
Glasgow aneurysm score, Leiden score or the modified Leiden score
[14]. The clinical importance of our observations is also related to the
fact that current treatment options for AAA are very limited. We are
able to monitor the progressive increase of AAA diameter, until the
criteria for surgical repair are fulfilled or the aneurysm ruptures. We
are unable to effectively slow down of prevent the development of the
disease [1,2].
We then analyzed the relationships between major individual AAA
risk factors (such as hypertension, smoking,male sex, dyslipidemia and
co-existing CAD) and vascular superoxide production. Previous studies,
including our own, have clearly shown that superoxide production
in human conduit vessels, such as saphenous veins, radial arteries or
human mammary arteries is closely linked to patient's age and major
risk factors for atherosclerosis [4,20–22]. This has not been addressed in
AAApatients before.Wehave found, that smoking, hypercholesterolemia
and co-existence of CAD are significantly associated with increased O2•−
production from the AAAwall. This is interesting, in particular in relationTable 3
Major risk factors for atherosclerosis and AAA in studied population in relation to
superoxide production. Data are shown as univariate analysis.
Risk factor Basal superoxide production
(RLU/s/mg dry weight)
p value
With RF Without RF
Male sex 8.44±2.55 29.82±14.16 0.22
Hypertension 31.55±12.73 22.56±10.2 0.45
Smoking 37.08±13.89 13.38±2.75 0.03
Hypercholesterolemia 40.36±16.23 13.89±3.28 0.013
Coronary artery disease 41.79±15.91 14.05±4.71 0.037to smoking,which is a very strong risk factor for the development of AAA.
This finding could provide a mechanistic link between smoking, in-
creased local vascular oxidative stress and the development of aneurysm.
Interestingly we did not observe significantly increased AAA super-
oxide production in relation to hypertension or male sex, which are the
most important risk factors for the AAA. At the same time we have now
observed the effect of dyslipidemia, which appears to be an emerging
risk factor for AAA [23]. Further explanation of these relationships will
require larger cohort studies focused on the role of hypertension and
dyslipidemia in oxidative stress related to. Due to relatively small sam-
ple size we did not perform multivariate analysis of the effect of risk
factors on vascular superoxide production, which should be a subject
for larger clinical studies. It should however be noted, that in our previous
studies of human vasculature, we have often not seen associations of
vascular ROS with hypertension in multivariate analysis even in much
larger studies [4]. This may be attributed to the effect of treatments for
hypertension, which are known to reduce ROS production [24].
While the oxidative stress has been defined in AAA before, the
enzymatic sources of ROS had remained unclear, making it difficult to
design specific interventions targeting oxidative stress. To address this
issue, we measured superoxide production following pre-incubation
with several oxidase inhibitors. Similar studies in conduit vessels of
patients undergoing coronary artery bypass grafts [3,25,26] or human
varicose veins [27] have shown that NADPH oxidases and eNOS and in
some cases xanthine oxidases, cyclooxygenases or mitochondrial oxi-
dases are the most important sources of superoxide anion in human
vessels[3,25,26]. Therefore in the present study we used inhibitors of
these oxidases, and we have found that NADPH oxidases, iNOS and to
the lesser extent cyclooxygenases contribute to net superoxide pro-
duction in sections of human AAA. This is in agreement with previous
studies in animal models of AAA, which had shown that NADPH oxi-
dases and iNOS are predominant sources of superoxide anion in AAA
[5,6]. Moreover, model studies using NADPH oxidase knockout had
shown that loss of functional NADPH oxidase inhibits generation and
progression of AAA [5,6].
In the present study, we demonstrate for the first time that aneurysm
size is closely correlated to NADPH oxidase activity, which provides fur-
ther argument for the role of this enzyme system in the progression and
development of the disease. Increased superoxide production can result
in the activation of metaloproteinases such asMMP-2 andMMP9, which
are critical for the development of AAA [5,6]. Moreover O2•− modulates
inflammatory reactions and can enhance leukocyte recruitment, which
contribute to AAA progression [1,5,6]. T is now important to unravel,
how are the NADPH oxidases activated in AAA. These enzymes have
been shown to be regulated by risk factors for atherosclerosis as well
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to similar clinical features, which we observed in AAA, can indicate, that
activation and increased expression of NADPH oxidases in aneurysmatic
vessel wall can be greatly affected by “simple” clinical risk factors of AAA
development.
Having identified NADPH oxidases as predominant sources of su-
peroxide anion in AAA, we characterized the molecular composition
of these enzymes in AAA. We identified, that nox2 and nox5 are the
predominant NADPH oxidase homologs expressed in aneurysmatic
vessel wall.
Oxidative stress is closely linked to inflammation in a variety of
cardiovascular disorders, including atherosclerosis, myocardial infarction,
atrial fibrillation [29] and others [30]. Therefore anti-oxidant based in-
terventions are considered to be potentially important for treatment
of number of inflammatory and cardiovascular disorders [31]. Increase
of NADPH oxidase activity and expression of Nox2 and p22phox
which we observed in AAA, may be in part related to inflammatory in-
filtration of the vessel wall, as we have previously observed in athero-
sclerotic human coronary arteries [20]. However, dihydroethidium
staining of the AAA wall indicates that superoxide production is ob-
served throughout the aneurysmatic aortic wall, and appears to be the
strongest at the adventitial side. We have performed additional experi-
ments in whichwemeasured LGCL from AAA section in which adventi-
tia or intima was facing the detector and repetitively we observed that
superoxide detectionwas particularly visible fromadventitial side (data
not shown). Future studies using immunohistochemistry and immuno-
fluorescence arewarranted to identify cellular sources of free radicals in
AAA.
The observation that nitric oxide synthases contribute to vascular
wall oxidative stress in AAA is very interesting. To our surprise we
noted that iNOS specific inhibitor 1400W caused greater degree of in-
hibition of superoxide production in AAA segments than pan-NOS in-
hibitor L-NAME. This, however, may be an indirect suggestion that in
AAA other NOS enzymes (eNOS and nNOS) are net contributors of NO
rather than superoxide, while iNOS is a net producer of superoxide
anion in AAA. This is related to nitric oxide synthase biology which,
depending on conditions such as tetrahydrobiopterin or L-arginine
availability, can produce either nitric oxide or superoxide [32,33].
Uncoupled NOS enzyme transfers electrons directly onto the molecular
oxygen, leading to the generation of superoxide anion rather than nitric
oxide. Uncoupling of vascularNOS can be functionally determined using
NOS inhibitors such as L-NAME due to the rapid interaction between
nitric oxide and superoxide [34]. If NOS produced nitric oxide, its inhibi-
tionwould lead to increase of superoxide bioavailability. If, in turn, NOS
produced net superoxide rather than NO, inhibition of NOS would lead
to decrease of superoxide released from the tissue [34]. Therefore the
difference between degree of O2•− inhibition by L-NAME and 1400W
clearly suggests that iNOS is a superoxide producing enzyme in AAA,
while other NOSmight still be able to produce nitric oxide. The observa-
tion of the dysfunction of iNOS, could indicate that tetrahydrobiopterin
supplementation, could be tested as a possible strategy to limit oxida-
tive stress in AAA.
While our study has focused on oxidant mechanisms, it is possible
that impaired anti-oxidant capacity may also play an important role in
oxidative stress in human AAA. Several studies in both animal models
and humans point to an imbalance and dysfunction of anti-oxidant en-
zymes in aortic abdominal aneurysms, in part in relation to clinical risk
factors such as hypertension [35,36]. SOD and other anti-oxidantmech-
anisms have been implicated in a number of cardiovascular diseases
[37,38]. We have also shown expression of superoxide dismutases in
human conduit vessels, although the role of these enzymes seemed
moderate when compared to superoxide generating enzymes [39].
While our study focused on local ROS production in the aneurysm,
we show here that these local events have systemic consequences,
which can be observed in plasma. Using HPLC with mass-spectrometry
detection we confirmed previous observations, that malondialdehydelevels, as a measure of systemic oxidant stress are significantly higher
in the plasma of AAA subjects [8]. The major advantage of the approach
presented in this paper is thatwe carefullymatched patients for age, sex,
and major clinical risk factors, which are known to affect vascular and
systemic oxidative stress. Such approach of matching subjects is partic-
ularly valuable in relation to variables such as superoxide production,
which are affected by common risk factors for atherosclerosis and was
previously successfully applied [16]. Here we show individual patient
pairs to demonstrate the very strong difference. This shows clearly,
that systemic oxidative stresswas very significantly increased in subjects
with AAA. The mechanism for this increase may be related to systemic
inflammatory reaction in AAA, or even more likely, to the generation of
reactive oxygen species locally in the aneurysmatic aorta. MDA levels
might be increased by aneurysm repair surgery itself [8], however it
was not the case in our study, as blood was drawn prior to surgery.
In the present studywe demonstrated, for thefirst time, a significant
correlation betweenNADPH-stimulated vascular superoxide anion pro-
duction in AAA segments and intra-operatively determined aneurysm
size. Previous studies have identified relationships between aneurysm
size and systemic oxidative stress, measured by MDA in human aneu-
rysms [8]. Demonstration that NADPH oxidase activity is correlated
with aneurysm sizemay further indicate the importance of this enzyme
in aneurysm progression and disease pathogenesis. More importantly,
it also shows the clinical impact of increased NADPH oxidase activity
in AAA, which indicates that NADPH oxidasesmay be valuable drug tar-
gets in human AAA.
5. Study limitations
Our study has certain limitations. Firstly, the sample size, although
larger than in the previous studies may not be sufficient for desired
multivariate epidemiological analysis of the effects of larger number
of clinical factors on oxidative stress parameters. Our study is so far
the largest to our knowledge to systematically quantify vascular su-
peroxide production in AAA samples in relation to clinical factors.
However, while we have pre-determined statistical power of compar-
isons, it cannot be excluded that lack of difference in vascular super-
oxide production in relation to hypertension or male sex may be
related to small number of patients without these risk factors in our
study population.
Our study focused solely on pro-oxidant mechanisms of oxidative
stress while the role of antioxidant systems in pathogenesis of AAA
has also been described. As emphasized in Materials and methods
section, we used pharmacological inhibitor approach to determine
the relative contribution of various vascular oxidases to AAA superox-
ide generation. While this approach is commonly employed, we must
remember that not all inhibitors are entirely specific. For example
apocynin, initially thought to be a specific inhibitor of NADPH oxidases
also have non-specific anti-oxidant properties [18]. In the present study,
we did not analyze individual layers of the aneurysm wall, in relation
to their contribution to superoxide production; therefore it is impossi-
ble to accurately determine the contribution of intima, media or adven-
titia to vascular superoxide production. Infiltrating inflammatory cells
may also contribute to oxidative stress in the tissue, but difficulty in
distinguishing these cells as a source of superoxide anion is inherent
to the approach of whole vessel studies used here. On the other hand,
measurements in human tissue have particular translational value, as
they give a direct insight into human disease, as opposed to animal or
cell culture models.
6. Conclusions
In conclusion, we have shown, that superoxide anion is widely
produced in human abdominal aortic aneurysms, and that it is partic-
ularly increased in adventitial surface of AAA. Its production is signif-
icantly related to aneurysm size, clinical risk factors for AAA and
2396 B. Guzik et al. / International Journal of Cardiology 168 (2013) 2389–2396atherosclerosis and is more than tripled in patients with highest mor-
tality risk. Nox2 and Nox5 based NADPH oxidases appear to be the
predominant contributors to oxidative stress in human AAA, while
iNOS may also contribute.
This may identify NADPH oxidases and uncoupled iNOS, as poten-
tially important drug targets for the treatment of oxidative stress in
aortic abdominal aneurysms. The search for novel pharmacological
therapies is particularly important, as we now rely almost exclusively
on invasive and surgical mechanical repair techniques [2]. Having
said that, our study clearly indicates, that intervention into classical
risk factors for AAA should be the first step in treating oxidative stress
in AAA.
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